Form 4: Glaukos Corp President & COO Joseph E. Gilliam Executes Stock Option and Sells Shares

Joseph E. Gilliam, President & COO of Glaukos Corporation, exercised stock options and sold shares of common stock on May 10, 2024, according to a Form 4 filing with the SEC.

Summary

• On May 10, 2024, Joseph E. Gilliam, the President & COO of Glaukos Corporation, exercised stock options to acquire 2,395 shares of common stock at a price of $55.18 per share.
• Simultaneously, Gilliam sold 2,395 shares of Glaukos common stock at a weighted average price of $110.56, with individual trades ranging from $110.36 to $111.22.
• These transactions were executed under a pre-arranged Rule 10b5-1 trading plan adopted on March 7, 2023.
• Following these transactions, Gilliam directly owns 101,845 shares of Glaukos common stock, which includes 76,419 unvested restricted stock units.
• He also holds options to purchase 38,239 shares of common stock.

Sentiment

Score: 5

Explanation: The sentiment is neutral as the filing simply reports transactions executed under a pre-existing trading plan. There is no indication of positive or negative sentiment towards the company's prospects.

Industry Context

Insider transactions are common, and the use of Rule 10b5-1 plans allows insiders to sell shares without being accused of trading on non-public information.

Comparison to Industry Standards

• It is common for executives at publicly traded companies to have stock option grants as part of their compensation packages.
• The use of 10b5-1 trading plans is a standard practice to avoid accusations of insider trading.
• Comparable companies such as Alcon and Johnson & Johnson also have executives who utilize similar trading plans.

Stakeholder Impact

• The transactions may have a minor impact on shareholders due to the change in ownership, but the pre-planned nature of the trades mitigates any significant concerns.

Key Dates